AbbVie Reports First-Quarter 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. USO
3. SPY
4. OPCH
5. BBIO
6. NVDA
7. GOOGL
8. CHRW
9. AMD
10. STZ

Go back to AbbVie Reports First-Quarter 2021 Financial Results

Abbvie (ABBV) PT Raised to $129 at BMO Capital

May 3, 2021 7:31 AM EDT

BMO Capital analyst Gary Nachman raised the price target on Abbvie (NYSE: ABBV) to $129.00 (from $127.00) while maintaining an Outperform rating.

The analyst commented, "1Q was high quality with solid top-line beat (mainly from Aesthetics and Immunology) dropping to bottom line, and improved diversification of... More

AbbVie (ABBV) Tops Q1 EPS by 12c, Offers FY Guidance

April 30, 2021 7:43 AM EDT

AbbVie (NYSE: ABBV) reported Q1 EPS of $2.95, $0.12 better than the analyst estimate of $2.83. Revenue for the quarter came in at $12.94 billion versus the consensus estimate of $12.76 billion.

GUIDANCE:

AbbVie sees FY2021 EPS of $12.37-$12.57, versus the consensus of... More